Jan Attig

13PUBLICATIONS

77CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyTumour immunologyMolecular targetsAvionics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Sep 16, 2026

T-cell dynamics, CD8/NK ratio and tumor survival hallmarks determine response to T-cell bispecific forimtamig in myeloma.

|Oct 30, 2024

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Jan Eckmann, Tanja Fauti, Marlene Biehl

|Apr 12, 2023

Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Kevin W Ng, Jesse Boumelha, Katey S S Enfield

|Jun 19, 2021

E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion.

Eleonora Ottina, Veera Panova, Laura Doglio

|Oct 20, 2020

Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.

Kevin W Ng, Jan Attig, William Bolland

|May 27, 2020

Antibody-induced internalisation of retroviral envelope glycoproteins is a signal initiation event.

Veera Panova, Jan Attig, George R Young

Pageof 3

Frequent Collaborators

George Young

George Kassiotis

Charles Swanton

Kevin Litchfield

Roberto Salgado

Oriol Pich

Katey S S Enfield

Takahiro Karasaki

Jorge Almagro

Veera Panova

Frequent Collaborators

George Young

George Kassiotis

Charles Swanton

Kevin Litchfield